V03AF01 - Mesna

Propably not porphyrinogenic

Rationale

Non-hepatic, probably non-CYP metabolism.

Chemical description

Sodium mercaptethane sulfonate administered during treatment with iophosphamide in order to counteract urinary tract toxicity caused by acroleine formed. Converted to free thiol in serum and eliminated in urine.

Similar drugs

Explore alternative drugs in similar therapeutic classes V03A / V03AF or go back.

References

Tradenames

Show more details and information about the listed tradenames

Uromitexan

Mesna · Uromitexan

Uromitexan

Mesna · Uromitexan

Uromitexan

Mesna · Uromitexan

Uromitexan

Mesna · Mesna-Cell · Uromitexan

In cooperation with IpNet

Acute Porphyria Drugs

V03AF01 - Mesna